Home

Pregnancy and fertility

Pregnant women must not use the Marshall ProtocolA curative medical treatment for chronic inflammatory disease. Based on the Marshall Pathogenesis. (MP). The MP may be begun only after delivery and when the baby is weaned.

Both olmesartan (Benicar)Medication taken regularly by patients on the Marshall Protocol for its ability to activate the Vitamin D Receptor. and minocyclineBacteriostatic antibiotic used by Marshall Protocol patients., the two mainstay medications of the MP, are contraindicated during pregnancy and while breastfeeding. When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus. When pregnancy is detected in women on the MP, they must discontinue olmesartan (Benicar) as soon as possible. Also, minocycline hydrochloride, like other tetracycline-class antibiotics, can cause fetal harm when administered to a pregnant woman.

Women who are contemplating pregnancy should consult with their physicians about treating inflammatory disease first. Women with inflammatory disease who are already pregnant should do everything possible to keep the level of 1,25-DPrimary biologically active vitamin D hormone. Activates the vitamin D nuclear receptor. Produced by hydroxylation of 25-D. Also known as 1,25-dihydroxycholecalciferol, 1,25-hydroxyvitamin D and calcitirol. down. This means diligent avoidance of ingested vitamin D and exposure to sunlight/bright lights.

Pregnancy increases 1,25-D

Production of 1,25-D is increased during pregnancy and may lead to disease exacerbation.

Pregnancy and sarcoidosis

The following describes some of the effects of sarcoidosis on pregnancy:

Other chronic inflammatory diseases seem to exert similar harmful effects.

Fathering children while on the MP

A man on the MP may be able to father children with a healthy female, however, bacteria causing Th1 disease can be transmitted during sexual contact and are transmissible to an ovum and/or a fetus.

MP may restore fertility

The MP is a curative therapy. As the MP resolves inflammation, this healing will likely restore sexual capability and fertility. Any or all aspects of the MP, including avoiding vitamin D and sunlight/bright lights, may contribute to hormonal changes which lead to restoration of health and fertility in men or women.

Therefore, women of childbearing age who are on the MP are advised to use adequate birth control measures to avoid an unwanted pregnancy. These women should consult with their health care practitioners at each phase of the MP about contraceptive medication and the use of low-dose, pulsed antibiotics. It is important to prevent pregnancy during the MP.

One of the MP cohort had been infertile for 15 years, but became pregnant at age 45, 6 months after starting the MP. She stopped to deliver and wean the baby and is now back on the MP.

Trevor Marshall, PhD

Birth control

Main article: Birth control

Women of childbearing age who are on the MP and sexually active are advised to use adequate birth control measures to avoid an unwanted pregnancy. Note that the MP can increase fertility.

Because the MP can increase or restore fertility, women of childbearing age who are on the MP and sexually active are advised to use adequate birth control measures to avoid an unwanted pregnancy.

The doses of hormones found in birth control are low enough that patients need not be excessively concerned with their effect on immune function.

→ Read more...

Patients experiences

I'm 54 years old and haven't had a period in two years and then had one in February. I am getting symptoms off and on of an impending cycle. Good thing I had my tubes tied years ago.

JudyBeauty

Related publications and presentations

References

2) Ellafi M, Valeyre D [Sarcoidosis and pregnancy] Rev Pneumol Clin. 1999;55:335-7.
3) Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, Friesen MH, Jacobson S, Kasapinovic S, Chang D, Diav-Citrin O, Chitayat D, Nulman I, Einarson TR, Koren G Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62:385-92.
home/special/pregnancy.txt · Last modified: 01.29.2010 (external edit)
© 2010, Autoimmunity Research Foundation. All Rights Reserved.